(Q30584718)

25 June 2017

title

Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data (English)

1 reference

25 June 2017

D Gaist

1

0 references

language of work or name

English

0 references

publication date

1 October 1999

1 reference

25 June 2017

1 reference

25 June 2017

volume

19

1 reference

25 June 2017

issue

8

1 reference

25 June 2017

page(s)

735-761

1 reference

From serotonin receptor classification to the antimigraine drug sumatriptan

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Is there a problem with long-term use of sumatriptan in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Epidemiology of headache in a general population--a prevalence study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Prevalence of migraine headache in Canada: a population-based survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Prevalence and sex-ratio of the subtypes of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Impact of headache on sickness absence and utilisation of medical services: a Danish population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

21 January 2018

Drug therapy of migraine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Cluster headache: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Cluster headache--clinical findings in 180 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Prevalence of migraine and cluster headache in Swedish men of 18

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Interrelations between migraine and tension-type headache in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Clinical applications of zolmitriptan (Zomig, 311C90).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

The Mode of Action of Sumatriptan is Vascular? A Debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Oral sumatriptan compared with placebo in the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Treatment of Acute Cluster Headache with Sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Subcutaneous sumatriptan during the migraine aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Long-term efficacy of subcutaneous sumatriptan using a novel self-injector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

The safety and tolerability of sumatriptan: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Psychoactivity and abuse potential of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Coronary vasospasm induced by subcutaneous sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Coronary vasospasm and sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Postmarketing study of cardiovascular adverse reactions associated with sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Cardiac arrest following use of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Adverse reactions attributed to sumatriptan. A postmarketing study in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Analgesic rebound headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Drug induced refractory headache--clinical features and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Methodology of clinical trials of sumatriptan in migraine and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Sumatriptan and daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Healthcare resource and lost labour costs of migraine headache in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

A population-based Danish data resource with possible high validity in pharmacoepidemiological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Individualized drug utilization statistics. Analysing a population's drug use from the perspective of individual users

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Presentation of a new instrument: the diagnostic headache diary

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Identification of patients treated with strong analgesics: an assessment of two Danish information systems with respect to epidemiological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Analyses of data quality in registries concerning diabetes mellitus--a comparison between a population based hospital discharge and an insulin prescription registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Registry evaluation methods: a review and case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

A framework for evaluation of secondary data sources for epidemiological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Primary non-compliance with prescribed medication in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Agreement between questionnaire data and medical records. The evidence for accuracy of recall

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Effect of questionnaire design on recall of drug exposure in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Sumatriptan in clinical practice: a 2-year review of 453 migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Ergotamine dependency--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Permanent global amnesia with unknown etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Ergotamine-induced headache can be sustained by sumatriptan daily intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Easy therapeutical management of sumatriptan-induced daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Headache syndromes and psychiatric disorders: association and familial transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Pattern of sumatriptan use and overuse in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients--a prescription database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Head injury as a risk factor for brain tumors in children: results from a multicenter case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Cancer risk in users of calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Analgesic rebound headache. How great is the problem and what can be done?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

Oral sumatriptan in acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008735.X

10.1046/J.1468-2982.1999.019008735.X

21 January 2018

Identifiers

DOI

1 reference

25 June 2017

1 reference